Repligen Corp (NASDAQ: RGEN) stock closed at $136.99 on 3/10/25 after a major decline of -12.0%. Moreover, this decline was accompanied by exceptionally high trading volume at 241% of normal. The stock has declined -14.0% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Repligen has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Repligen has a poor Appreciation Score of 18 but a neutral Power Rating of 59, resulting in the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment